NASA developed Ventilator authorised by FDA, 3 Indian companies among licensees
Published on : Tuesday 02-06-2020
Called VITAL (Ventilator Intervention Technology Accessible Locally), the device was developed by engineers at NASAs Jet Propulsion Laboratory.
June 2020 – Three Indian companies have got licences from NASA to manufacture its indigenously developed ventilators for critical Covid-19 patients. The three Indian companies are Alpha Design Technologies Pvt Ltd, Bharat Forge Ltd and Medha Servo Drives Pvt Ltd, a NASA release stated. Apart from the Indian firms, 18 other companies, including eight American and three Brazilian, have been selected to manufacture the critical breathing devices. The National Aeronautics and Space Administration (NASA) developed the ventilator specifically for coronavirus patients at its Jet Propulsion Laboratory (JLP) in Southern California. This was approved by the Food and Drug Administration (FDA) for use under the FDA’s March 24 ventilator Emergency Use Authorisation.
Called VITAL (Ventilator Intervention Technology Accessible Locally), the device was developed by engineers at NASA's Jet Propulsion Laboratory (JPL) in Southern California to free up the nation's limited supply of traditional ventilators so they may be used on patients with the most severe Covid-19 symptoms.
“This FDA authorisation is a key milestone in a process that exemplifies the best of what government can do in a time of crisis,” said NASA Administrator Jim Bridenstine. “This ventilator is one of countless examples of how taxpayer investments in space exploration – the skills, expertise and knowledge collected over decades of pushing boundaries and achieving firsts for humanity – translate into advancements that improve life on Earth.”
The Office of Technology Transfer and Corporate Partnerships at Caltech, which manages JPL for NASA, is offering a free license for VITAL and is reaching out to the commercial medical industry to find manufacturers for the device.
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)